Baseline metabolic signatures predict clinical outcomes in immunotherapy-treated melanoma patients: a pilot study.

De Summa S, De Palma G, Ghini V, Apollonio B, De Risi I, Tufaro A, Strippoli S, Luchinat C, Tenori L, Guida M

Open source

DOI
10.3389/fimmu.2025.1536710
Published
2025
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2025.1536710,
  title = {Baseline metabolic signatures predict clinical outcomes in immunotherapy-treated melanoma patients: a pilot study.},
  author = {De Summa S and De Palma G and Ghini V and Apollonio B and De Risi I and Tufaro A and Strippoli S and Luchinat C and Tenori L and Guida M},
  year = {2025},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2025.1536710},
  url = {https://doi.org/10.3389/fimmu.2025.1536710}
}

RIS

TY  - JOUR
TI  - Baseline metabolic signatures predict clinical outcomes in immunotherapy-treated melanoma patients: a pilot study.
AU  - De Summa S
AU  - De Palma G
AU  - Ghini V
AU  - Apollonio B
AU  - De Risi I
AU  - Tufaro A
AU  - Strippoli S
AU  - Luchinat C
AU  - Tenori L
AU  - Guida M
PY  - 2025
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2025.1536710
UR  - https://doi.org/10.3389/fimmu.2025.1536710
ER  - 

APA

S, D. S., G, D. P., V, G., B, A., I, D. R., A, T., S, S., C, L., L, T., & M, G. (2025). Baseline metabolic signatures predict clinical outcomes in immunotherapy-treated melanoma patients: a pilot study.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2025.1536710

Source records